Synopsys Stock Today
| SNPS Stock | USD 508.77 14.58 2.95% |
PerformanceWeak
| Odds Of DistressLow
|
Synopsys is selling for under 508.77 as of the 6th of January 2026; that is 2.95 percent increase since the beginning of the trading day. The stock's lowest day price was 494.05. Synopsys has only a 8 % chance of going through financial distress over the next few years but had a somewhat weak performance during the last 90 days. Note, on November 14, 2025, Representative Ro Khanna of US Congress acquired under $15k worth of Synopsys's common stock.
Business Domain Software & Services | IPO Date 26th of February 1992 | Category Technology | Classification Information Technology |
Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company was incorporated in 1986 and is headquartered in Mountain View, California. Synopsys operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. The company has 191.32 M outstanding shares of which 4.41 M shares are at this time shorted by private and institutional investors with about 1.86 trading days to cover. More on Synopsys
Moving together with Synopsys Stock
Moving against Synopsys Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Synopsys Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO | Sassine Ghazi | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Application Software, Software - Infrastructure, Information Technology, Nasdaq 100, NASDAQ Composite, SP 500 Index, Nasdaq CTA Artificial, NASDAQ 100 Equal, NASDAQ 100 Technology, Nasdaq Computer, NASDAQ 100 Pre, NASDAQ Composite Total, Information Technology, Software, Software—Infrastructure, Technology, Computing (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsSynopsys can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Synopsys' financial leverage. It provides some insight into what part of Synopsys' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Synopsys (SNPS) is traded on NASDAQ Exchange in USA and employs 28,000 people. Synopsys is listed under Application Software category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 94.55 B. Synopsys conducts business under Software sector and is part of Information Technology industry. The entity has 191.32 M outstanding shares of which 4.41 M shares are at this time shorted by private and institutional investors with about 1.86 trading days to cover.
Synopsys currently holds about 1.53 B in cash with 1.52 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.01.
Check Synopsys Probability Of Bankruptcy
Ownership AllocationSynopsys shows a total of 191.32 Million outstanding shares. The majority of Synopsys outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Synopsys to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Synopsys. Please pay attention to any change in the institutional holdings of Synopsys as this could imply that something significant has changed or is about to change at the company. On November 14, 2025, Representative Ro Khanna of US Congress acquired under $15k worth of Synopsys's common stock.
Check Synopsys Ownership Details
Synopsys Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Pictet Asset Manangement Sa | 2025-06-30 | 2.5 M | |
| Ubs Asset Mgmt Americas Inc | 2025-06-30 | 1.9 M | |
| Van Eck Associates Corporation | 2025-06-30 | 1.9 M | |
| Alliancebernstein L.p. | 2025-06-30 | 1.9 M | |
| Morgan Stanley - Brokerage Accounts | 2025-06-30 | 1.9 M | |
| Clearbridge Advisors, Llc | 2025-06-30 | 1.6 M | |
| Northern Trust Corp | 2025-06-30 | 1.6 M | |
| Amvescap Plc. | 2025-06-30 | 1.6 M | |
| Aristotle Capital Management Llc | 2025-06-30 | 1.6 M | |
| Vanguard Group Inc | 2025-06-30 | 15.1 M | |
| Blackrock Inc | 2025-06-30 | 12.8 M |
Synopsys Historical Income Statement
Synopsys Stock Against Markets
Synopsys Corporate Management
| Shankar Krishnamoorthy | Head Development | Profile | |
| Shelagh Glaser | Chief Officer | Profile | |
| Charlie Matar | Senior Group | Profile | |
| John Runkel | General Counsel and Corporate Secretary | Profile | |
| Deirdre Hanford | Chief Officer | Profile |
Additional Tools for Synopsys Stock Analysis
When running Synopsys' price analysis, check to measure Synopsys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synopsys is operating at the current time. Most of Synopsys' value examination focuses on studying past and present price action to predict the probability of Synopsys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synopsys' price. Additionally, you may evaluate how the addition of Synopsys to your portfolios can decrease your overall portfolio volatility.